Liesenfeld, Lukas
[Author];
Wagner, Benedikt
[Author];
Hillebrecht, Christian
[Author];
Brune, Maik
[Author];
Eckert, Christoph
[Author];
Klose, Johannes
[Author];
Schmidt, Thomas
[Author];
Büchler, Markus W.
[Author];
Schneider, Martin
[Author]
Description:
Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with cytoreductive surgery (CRS) is the treatment of choice for selected patients with peritoneal malignancies. HIPEC is accompanied by moderate-to-high patient morbidity, including acute kidney injury. The significance of nephrotoxic agents such as cisplatin versus hyperthermia in HIPEC-induced nephrotoxicity has not been defined yet.